Australian-backed investment to support global commercial scale-up of HyperVIEW™ across healthcare and mining industrial applications Australia, June 2026 - Hancock Prospecting has provided an initial US$50 million investment into Lumitron, with the right to increase its investment to US$100 million during the 2026 calendar year. The funding will support the commercial scale-up and deployment of the company’s HyperVIEW™ Very High Energy Electron (VHEE) beam and advanced X-ray

On April 22, Lumitron’s co-founder and CTO, Dr. Chris Barty, presented one of three plenary lectures at this years Optics and Photonics International Congress (OPIC) in Yokohama, Japan. OPIC and the associated Optics and Photonics International Exhibition (OPIE) brings together several thousand attendees annually spanning virtually all optics and photonics related industries and science. Dr. Barty’s lecture introduced the core, patented, accelerator and laser technologies w

A Southern California company called Lumitron has developed a new kind of x-ray system. It uses advanced electron beam technology to see cancer at a cellular level. This system called "hyper-view" can deliver ultra-detailed images with up to one-thousand times more clarity than standard x-rays while using 100-times less radiation. The technology could make cancer treatment safer and more effective. Founder of Lumitron, Dr. Chris Barty explains how it all works and the benefit

Recent study concludes Lumitron’s laser-Compton X-ray source can improve tumor detection by more than 3000% relative to today’s standards Irvine, CA - Contrast-enhanced mammography (CEM) using traditional X-ray tubes is an advanced imaging technique that improves breast cancer detection rates, particularly for patients with dense or thick breast tissue. According to simulations published recently in Medical Physics, Lumitron's HyperVIEW™ has the ability to improve upon existi

FDA Grants Designation

Peer-Reviewed article describes Lumitron's HyperVIEW™ revolutionary technology Irvine, CA – The ultimate goal of modern radiotherapy is to effectively destroy cancer cells while preserving healthy tissue. FLASH bursts of very high-energy electrons (VHEE) have emerged as a promising and cost-effective approach to achieving this ambitious objective. Lumitron Technologies has created with its HyperVIEW™ image-guided, radiotherapy platform the world's first compact VHEE, FLASH-re

Lumitron Technologies advances the practical application of FLASH radiotherapy IRVINE, CA -- Lumitron Technologies, Inc., a company pioneering the development of a unique x-ray system, HyperVIEW™ EBCS, today announced its underlying accelerator technology has successfully generated electron beams that, for the first time, enable electron FLASH radiotherapy for a variety of next generation cancer treatments. “Our accelerator has produced a train of 100 consecutive, high-ch

Proton FLASH Radiotherapy, Hailed by Publication As 'Breakthrough', Also Being Pioneered By Lumitron Technologies With Electrons. Physics World (PW) unveiled is annual list of breakthroughs this December showcasing its Top 10 innovations of 2022. A panel of PW editors made their selections based on the following criteria: Significant advance in knowledge or understanding Importance of work for scientific progress and/or development of real-world applications Of general inter

Citing Breakthrough Medical Applications, CERN Follows Pioneering Lumitron Technologies on Development of Electron-Based Technology. In 2020, CERN, the world's leading organization for particle accelerator research, announced that it would form a collaboration to develop a radiotherapy facility to exploit the FLASH effect from the use of very high-electrons (VHEE). This new focus on radiotherapy by CERN confirms that Lumitron Technologies’ groundbreaking multi-bunch work in t

Lumitron Technologies CEO, Dr. Chris Barty published a recent article with OPTICA Publishing Group evaluating the high-energy, laser-Compton X-Ray. Co-written with Trevor Reutershan, Haytham H. Effarah, Agnese Lagzda, the publication provides a numerical evaluation of the technology's sources for contrast enhancement and dose reduction in clinical imaging via gadolinium-based K-edge subtraction. From the articles Abstract: Conventional x-ray sources for medical imaging utili